Twist Graham Number from 2010 to 2024

TWST Stock  USD 48.32  1.98  4.27%   
Twist Bioscience Graham Number yearly trend continues to be comparatively stable with very little volatility. Graham Number will likely drop to 20.27 in 2024. From the period from 2010 to 2024, Twist Bioscience Graham Number quarterly data regression had r-value of  0.77 and coefficient of variation of  32.39. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
25.68144758
Current Value
20.27
Quarterly Volatility
6.94581351
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Check out the analysis of Twist Bioscience Correlation against competitors.

Latest Twist Bioscience's Graham Number Growth Pattern

Below is the plot of the Graham Number of Twist Bioscience Corp over the last few years. It is Twist Bioscience's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Twist Bioscience's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

Twist Graham Number Regression Statistics

Arithmetic Mean21.45
Geometric Mean20.46
Coefficient Of Variation32.39
Mean Deviation5.58
Median21.35
Standard Deviation6.95
Sample Variance48.24
Range21.8271
R-Value0.77
Mean Square Error21.23
R-Squared0.59
Significance0.0008
Slope1.19
Total Sum of Squares675.42

Twist Graham Number History

2024 20.27
2023 25.68
2022 29.78
2021 36.51
2020 29.22
2019 26.25
2018 22.1

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as Graham Number, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Graham Number 25.68  20.27 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.